Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD
Public ClinicalTrials.gov record NCT02634177. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
In this randomized clinical trial, subjects will be assigned to either an assay-guided treatment condition (AGT) or a treatment-as-usual condition (TAU). All subjects will provide a DNA sample at the Screening Visit for the Genecept Assay ™. In the AGT condition, assay results will be provided to the treating investigator, who will use the results to guide antidepressant pharmacotherapy. In the TAU condition, the investigator will treat the subjects without the knowledge of the pharmacogenetic testing results. Assay results for all subjects will be provided to the investigator once all Week 8 visit procedures have been completed. Raters of the primary endpoint assessment and subjects will remain blinded to treatment assignment.
Study identification
- NCT ID
- NCT02634177
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 305 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 2016 (Type not available)
- Primary completion
- Jul 25, 2017 (Actual)
- Completion
- Jul 25, 2017 (Actual)
- Last update posted
- Aug 28, 2020
2016 – 2017
United States locations
- U.S. sites
- 23
- U.S. states
- 15
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama - Birmingham | Birmingham | Alabama | 35294 | — |
| Noesis Pharma | Phoenix | Arizona | 85032 | — |
| Woodland Research Northwest | Springdale | Arkansas | 72764 | — |
| Collaborative Neuroscience Network, Inc. - Garden Grove | Garden Grove | California | 92845 | — |
| Pacific Institute of Medical Research | Los Angeles | California | 90024 | — |
| Pacific Research Partners, LLC | Oakland | California | 94612 | — |
| Artemis Institute for Clinical Research | San Diego | California | 92103 | — |
| Collaborative Neuroscience Network, Inc. - Torrance | Torrance | California | 90502 | — |
| Pacific Clinical Research Medical Group | Upland | California | 91786 | — |
| Florida Clinical Research Center, LLC - Bradenton | Bradenton | Florida | 34201 | — |
| Clinical Neuroscience Solutions Inc. - Jacksonville | Jacksonville | Florida | 32256 | — |
| Florida Clinical Research Center, LLC - Maitland | Maitland | Florida | 32751 | — |
| Clinical Neuroscience Solutions Inc. - Orlando | Orlando | Florida | 32801 | — |
| Chicago Research Center, Inc. | Chicago | Illinois | 60634 | — |
| Boston Clinical Trials | Boston | Massachusetts | 02131 | — |
| Premier Psychiatric Research Institute, LLC | Lincoln | Nebraska | 68526 | — |
| Richard H Weisler MD, PA and Associates | Raleigh | North Carolina | 27609 | — |
| Midwest Clinical Research Center | Dayton | Ohio | 45417 | — |
| IPS Research Company | Oklahoma City | Oklahoma | 73103 | — |
| Thomas Jefferson University Mood Disorder Program | Philadelphia | Pennsylvania | 19107 | — |
| Clinical Neuroscience Solutions Inc. - Memphis | Memphis | Tennessee | 38119 | — |
| BioBehavioral Research of Austin, PC | Austin | Texas | 78759 | — |
| University of Virginia Center for Psychiatric Research | Charlottesville | Virginia | 22903 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02634177, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 28, 2020 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02634177 live on ClinicalTrials.gov.